Related Experiment Video
Updated: Jan 16, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
Validation of a clinical decision aid to discontinue in-hospital cardiac arrest resuscitations
C van Walraven1, A J Forster, D C Parish
1Department of Medicine, University of Ottawa, Ontario, Canada. carlv@lri.ca
A new clinical decision aid accurately identifies patients likely to survive in-hospital cardiac resuscitation. This tool helps physicians determine when continued resuscitation efforts may not benefit patients, improving resource allocation.
Area of Science:
- Emergency Medicine
- Cardiology
- Clinical Decision Support
Background:
- In-hospital cardiac resuscitation survival rates remain low.
- A prior study developed a clinical decision aid to predict survival to discharge.
- This study aimed to validate that previously derived decision aid.
Purpose of the Study:
- To validate a previously developed clinical decision aid for predicting survival to hospital discharge after in-hospital cardiac resuscitation.
- To assess the accuracy of the decision aid in identifying patients unlikely to benefit from continued resuscitation.
Main Methods:
- Analysis of a large registry of in-hospital cardiac resuscitation attempts (n=2181) from 1987-1996.
- The decision aid predicted survival based on witnessed arrest, initial cardiac rhythm (ventricular tachycardia/fibrillation), or pulse regained within 10 minutes.
- Predictions were compared against actual hospital discharge outcomes.
Main Results:
- The decision aid correctly predicted survival to discharge for 99.1% of survivors (sensitivity).
- For patients predicted to have no chance of survival (n=269), only 1.1% were discharged, and none independently.
- The negative predictive value of the aid was 98.9%.
Conclusions:
- The validated clinical decision aid accurately identifies patients unlikely to survive in-hospital cardiac resuscitation.
- This tool can assist physicians in making informed decisions about continuing resuscitative efforts.
- The aid supports better resource allocation by identifying patients with extremely low likelihood of beneficial outcomes.
Related Concept Videos
07:52In Vivo CRISPR/Cas9 Screening to Simultaneously Evaluate Gene Function in Mouse Skin and Oral Cavity
08:54In vivo Application of the REMOTE-control System for the Manipulation of Endogenous Gene Expression
11:53A Protocol for Multiple Gene Knockout in Mouse Small Intestinal Organoids Using a CRISPR-concatemer
10:19Generation of Genetically Modified Mice through the Microinjection of Oocytes
13:10DNA Vector-based RNA Interference to Study Gene Function in Cancer
10:58Quantitative and Automated High-throughput Genome-wide RNAi Screens in C. elegans

